{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:50:36Z","timestamp":1792792236409,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Breast Cancer Association"},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3361-y","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T12:30:23Z","timestamp":1495801823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial"],"prefix":"10.1186","volume":"17","author":[{"name":"on behalf of the SENOMAC Trialists\u2019 Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-0902","authenticated-orcid":false,"given":"Jana","family":"de Boniface","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frisell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bergkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemming","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lundstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"issue":"1","key":"3361_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181\u20137.","journal-title":"Cancer"},{"issue":"9","key":"3361_CR2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52(9):1551\u20137.","journal-title":"Cancer"},{"issue":"3","key":"3361_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-007-9556-1","volume":"107","author":"I Soerjomataram","year":"2008","unstructured":"Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107(3):309\u201330.","journal-title":"Breast Cancer Res Treat"},{"key":"3361_CR4","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th Edition. ISBN: 978-1-4443-3241-4 ed. Oxford: Wiley-Blackwell; 2009."},{"issue":"Suppl 4","key":"3361_CR5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s002590050572","volume":"26","author":"OE Nieweg","year":"1999","unstructured":"Nieweg OE, Jansen L, Vald\u00e9s Olmos RA, Rutgers E, Peterse JL, Hoefnagel KA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med. 1999;26(Suppl 4):S11\u20136.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"3361_CR6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bjs.7820","volume":"99","author":"Y Andersson","year":"2012","unstructured":"Andersson Y, de Boniface J, J\u00f6nsson PE, Ingvar C, Liljegren G, Bergkvist L, et al. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer. Br J Surg. 2012;99(2):226\u201331.","journal-title":"Br J Surg"},{"issue":"10","key":"3361_CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary- lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3361_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-010-1210-7","volume":"125","author":"MJ Pepels","year":"2011","unstructured":"Pepels MJ, Vesthens JH, de Boer M, Smidt M, van Diest PJ, Borm GF, et al. Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat. 2011;125(2):301\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3361_CR9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejso.2008.01.034","volume":"34","author":"IM Ploeg van der","year":"2008","unstructured":"van der Ploeg IM, Nieweg OE, van Rijk MC, Vald\u00e9s Olmos RA, Kroon BB. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34(12):1277\u201384.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"3361_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejca.2004.05.009","volume":"41","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41(2):231\u20137.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3361_CR11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/02841850701305440","volume":"48","author":"F Celebioglu","year":"2007","unstructured":"Celebioglu F, Perbeck L, Frisell J, Gr\u00f6ndal E, Svensson L, Danielsson R. Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery. Acta Radiol. 2007;48(5):488\u201395.","journal-title":"Acta Radiol"},{"issue":"25","key":"3361_CR12","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","volume":"28","author":"SR Land","year":"2010","unstructured":"Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol. 2010;28(25):3929\u201336.","journal-title":"J Clin Oncol"},{"issue":"24","key":"3361_CR13","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencrantz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657\u201363.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3361_CR14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/bjs.9401","volume":"101","author":"H Sackey","year":"2014","unstructured":"Sackey H, Magnuson A, Sandelin K, Liljegren G, Bergkvist L, F\u00fclep Z, et al. Arm lymphoedema after axillary surgery in women with invasive breast cancer. Br J Surg. 2014;101(4):390\u20137.","journal-title":"Br J Surg"},{"issue":"11","key":"3361_CR15","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/cncr.11803","volume":"98","author":"AC Degnim","year":"2003","unstructured":"Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, et al. Clinicopathologic eatures of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer. 2003;98(11):2307\u201315.","journal-title":"Cancer"},{"issue":"6","key":"3361_CR16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencrantz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"10","key":"3361_CR17","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","volume":"19","author":"AS Caudle","year":"2012","unstructured":"Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, et al. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol. 2012;19(10):3144\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3361_CR18","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1245\/s10434-012-2523-z","volume":"19","author":"SM Gainer","year":"2012","unstructured":"Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012;19(10):3152\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3361_CR19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10585-012-9515-z","volume":"29","author":"AE Giuliano","year":"2012","unstructured":"Giuliano AE, Morrow M, Duggal S, Julian TB. Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis. 2012;29(7):687\u201392.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"3361_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1503\/cjs.036011","volume":"55","author":"S Latosinsky","year":"2012","unstructured":"Latosinsky S, Berrang TS, Cutter CS, George R, Olivotto I, Julian TB, et al. CAGS and ACS evidence based reviews in surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg. 2012;55(1):66\u20139.","journal-title":"Can J Surg"},{"key":"3361_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3361_CR22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.sla.0000250439.86020.85","volume":"245","author":"J Park","year":"2007","unstructured":"Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS 3rd. A declining rate of completion axillary dissection in sentinel lymph node- positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007;245(3):462\u20138.","journal-title":"Ann Surg"},{"issue":"1","key":"3361_CR23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","volume":"255","author":"MJ Pepels","year":"2012","unstructured":"Pepels MJ, de Boer M, Bult P, van Dijck JA, van Deurzen CH, Menke-Pluymers MB, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg. 2012;255(1):116\u201321.","journal-title":"Ann Surg"},{"key":"3361_CR24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive senintel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"6","key":"3361_CR25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2522\/ptj.20100087","volume":"91","author":"N Devoogdt","year":"2011","unstructured":"Devoogdt N, De Groef A, Hendrickx A, Damstra R, Christiaansen A, Geraerts I, et al. Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91(6):944\u201357.","journal-title":"Phys Ther"},{"issue":"10","key":"3361_CR26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"5","key":"3361_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"3361_CR28","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"K Bjordal","year":"2000","unstructured":"Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796\u2013807.","journal-title":"Eur J Cancer"},{"key":"3361_CR29","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organisation for Research and Treatment of Cancer Breast Cancer Specific Quality of Life Questionnaire Module: first results from a three-country field study. J Clin Oncol. 1996;14:2756\u201368.","journal-title":"J Clin Oncol"},{"key":"3361_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"BV Offersen","year":"2015","unstructured":"Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114:3\u201310.","journal-title":"Radiother Oncol"},{"issue":"6","key":"3361_CR31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/0284186X.2015.1136751","volume":"55","author":"A Gondos","year":"2016","unstructured":"Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, et al. Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers. Acta Oncol. 2016;55(6):712\u20139.","journal-title":"Acta Oncol"},{"issue":"3","key":"3361_CR32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencrantz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z001 randomized trial. Ann Surg. 2016;264(3):413\u201320.","journal-title":"Ann Surg"},{"key":"3361_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40064-016-1712-9","volume":"5","author":"M Schmidt-Hansen","year":"2016","unstructured":"Schmidt-Hansen M, Bromham N, Haster E, Reed MW. Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses. Spring. 2016;5:85.","journal-title":"Spring"},{"issue":"1","key":"3361_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/000313481608200124","volume":"82","author":"TC Kenny","year":"2016","unstructured":"Kenny TC, Dove J, Shabahang M, Woll N, Hunsinger M, Morgan A, et al. Widespread implications of ACOSOG Z0011: effect on total mastectomy patients. Am Surg. 2016;82(1):53\u20138.","journal-title":"Am Surg"},{"key":"3361_CR35","doi-asserted-by":"crossref","unstructured":"Ataseven B, von Minckwitz G. The impact of neoadjuvant treatment on surgical options and outcomes. Ann Surg Oncol. 2016; [Epub ahead of print]","DOI":"10.1245\/s10434-016-5364-3"},{"issue":"7","key":"3361_CR36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T17:13:38Z","timestamp":1602177218000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3361-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]},"article-number":"379"}}